Thema: INE089A01023
Dr Reddy, INE089A01023
iphone-5183941_1920.jpg - Foto: THN
Dr. Reddy's stock: Brazil approves generic semaglutide
Dr. Reddy's stock gains a new Brazil opportunity after ANVISA approved its generic semaglutide injection. Aché will support the launch.
ad-hoc-news.de, heute 01:02 Uhr
Dr Reddy, INE089A01023
Dr. Reddy s reports Q2 results: BNP target for Dr. Reddy ...
Q2 revenue fell 1.5 percent year over year to INR 86.71 billion. For Dr Reddy stock, semaglutide targets a November 2026 relaunch.
ad-hoc-news.de, 25.10.26 02:10 Uhr
Dr Reddy, INE089A01023
Wall Street Zen upgrades Dr Reddy to Hold: what it means ...
Dr Reddy disclosed three FDA observations on October 14, 2026. Q2 results arrive October 23, and the consensus rating for Dr Reddy stock is Hold.
ad-hoc-news.de, 20.10.26 10:25 Uhr
Dr Reddy, INE089A01023
Dr Reddy reports three FDA observations: what it means for ...
Dr Reddy disclosed three FDA observations at FTO-9 on October 14, 2026. Dr Reddy stock enters October 23 results with Q2 profit up 77.00 percent.
ad-hoc-news.de, 15.10.26 10:22 Uhr
Dr Reddy, INE089A01023
Dr Reddy stock trades at INR 1,211.20 before October 23 ...
Dr Reddy sets results for October 23, 2026. Dr Reddy stock trades at INR 1,211.20 on BSE, down 2.29 percent versus INR 1,239.65.
ad-hoc-news.de, 14.10.26 11:53 Uhr
Dr Reddy, INE089A01023
Dr Reddy stock at INR 1,229.40 13.1 percent below its high ...
The P/E ratio is 30.96 versus Sun Pharma at 34.91. Dr Reddy stock was last at INR 1,229.40 on October 12, 2026, below INR 1,414.90.
ad-hoc-news.de, 12.10.26 13:01 Uhr
Dr Reddy, INE089A01023
Dr Reddy reports two FDA observations: Citi targets Dr Reddy ...
Revenue fell 5.60 percent to INR 80.71 billion in April-June 2026. Citi sees INR 1,450 for Dr Reddy stock, up from INR 1,040 on September 29, 2026.
ad-hoc-news.de, 12.10.26 09:56 Uhr
Dr Reddy, INE089A01023
Dr Reddy stock at INR 1,197.00 up 1.4 percent today. INE089A01023 ...
Dr Reddy stock costs INR 1,197.00 on October 9, 2026 after INR 1,180.00. Volume reached 1,510,225 shares.
ad-hoc-news.de, 09.10.26 15:08 Uhr
Dr Reddy, INE089A01023
Dr Reddy reports FDA observations: what it means for Dr ...
The FTO-11 inspection produced two FDA observations. For Dr Reddy stock, Q1 profit fell 69.00 percent before results on October 23, 2026.
ad-hoc-news.de, 09.10.26 12:21 Uhr
Dr Reddy, INE089A01023
Citi raises target for Dr Reddy's Laboratories stock to ...
